メインのコンテンツにスキップする

申し訳ございませんが、お客様のブラウザには完全に対応しておりませんオプションがありましたら、新しいバージョンにアップグレードするか、 Mozilla Firefox、 Microsoft Edge、Google Chrome、またはSafari 14以降をお使いください。これらが利用できない場合、またサポートが必要な場合は、フィードバックをお送りください。

Elsevier
論文を投稿する
Announcement

Elsevier’s ClinicalKey Student adds StudyFinder AI to quickly connect medical students to trusted, verifiable content for more efficient studying

2026年6月25日

The addition of StudyFinder AI and Osmosis AI combines trusted content from books, videos and 3D models with user-centric AI to improve efficiency and productivity in medical education

Elsevier has added StudyFinder AI to ClinicalKey Student to deliver trusted AI to medical education. 74%1 of today’s medical students already use AI to support their studies, but many generic tools provide unverified answers lacking context, accuracy and transparency. Building on the launch of Osmosis AI earlier this year, the addition of StudyFinder AI allows students to use ClinicalKey Student to access trusted, evidence-based content quicker and more efficiently than ever before.

Addressing the growing demand for trusted AI in healthcare education, the enhanced ClinicalKey Student eliminates the risks often associated with generic AI alternatives. StudyFinder AI will initially be available in the UK, Australia and New Zealand, while Osmosis AI is currently available globally.

Brent Gordon, President of Elsevier Healthcare Education, said: “Most AI tools available to students today lack answers supported by trusted and verifiable sources. ClinicalKey Student is different − every StudyFinder AI response is drawn from content that medical schools recommend, including Elsevier’s evidence-based content, and is instantly verifiable. This is critical for students learning how to make clinical decisions.”

StudyFinder AI supports medical students in the following ways:

  • AI-driven search capabilities allow students to study more efficiently, quickly connecting them to trusted, curriculum-aligned resources

  • Embedded citations mean students can be confident they are using verified sources when studying

  • Allows students to ask questions and search topics, visualize with 2D and 3D models, and create visual aids for studying

  • Allows students to draw from a curated selection of evidence-based textbooks, over 6,000 multiple-choice questions and over 1,000 bite-sized videos

Nadya Affendy, a current UK medical student, said:“A key part of medicine is evidence-based learning which isn’t guaranteed by a lot of AI tools. That’s what stood out about StudyFinder; the AI bases itself off of trusted sources from Elsevier textbooks, as well as the NICE guidelines – the same kind of textbooks which are recommended by professors and lecturers throughout medical school.”

The announcement follows the launch of Osmosis AI in March this year, which provides the following capabilities:

  • Combines award-winning Osmosis videos, trusted Elsevier medical content (including the most authoritative textbooks) and responsible AI to provide timely support for students and educators

  • Connects answers directly to Osmosis videos students already rely on, and provides clear citations for verification

  • Prioritises high yield, clinically relevant explanations aligned with medical curricula and board exams

Elsevier Healthcare Education also plans to launch its AI-powered Assessment Creator this summer in select markets as part of a new enterprise solution for medical education, saving faculty valuable time when creating curriculum-aligned, evidence-based assessments.

Find out more about ClinicalKey Student here.

[1] Internal research study of 250 medical students (2025)

エルゼビアについて

エルゼビアは、先端情報と意思決定を支援しています。1世紀以上にわたり、人類の進歩のため先端科学とヘルスケアの進歩に貢献してきました。私たちは、170か国にわたるアカデミアや企業の研究コミュニティ、医師、看護師、未来の医療従事者、教育者の皆さまの重要な活動をサポートしています。これは、信頼できるエビデンスに基づく科学・医療コンテンツと高度なAI技術を組み合わせた革新的なソリューションにより知見の集積や重要な意思決定を支援することで実現しています。また、私たちは、これらの価値を製品や企業文化に組み込み、コミュニティとの協働を通じて、インクルージョンと持続可能性を推進しています。エルゼビア財団opens in new tab/windowは、世界中の研究と医療のパートナーシップを支援しています。

エルゼビアは、専門家およびビジネス向けの情報分析および意思決定ツールのグローバルプロバイダーであるRELX Groupopens in new tab/windowの一事業を担っています。詳細につきましては、www.elsevier.comまたはソーシャルメディア@Elsevier Connectをご覧ください。

連絡先

Chris West

Chris West

Director, Health Markets

Elsevier

+1 571 687 2942

E-mail Chris West